These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17553237)

  • 1. Meningitis serogroup W135 outbreak, Burkina Faso, 2002.
    Nathan N; Rose AM; Legros D; Tiendrebeogo SR; Bachy C; Bjørløw E; Firmenich P; Guerin PJ; Caugant DA
    Emerg Infect Dis; 2007 Jun; 13(6):920-3. PubMed ID: 17553237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.
    Traoré Y; Njanpop-Lafourcade BM; Adjogble KL; Lourd M; Yaro S; Nacro B; Drabo A; Parent du Châtelet I; Mueller JE; Taha MK; Borrow R; Nicolas P; Alonso JM; Gessner BD
    Clin Infect Dis; 2006 Oct; 43(7):817-22. PubMed ID: 16941360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.
    Boisier P; Djibo S; Sidikou F; Mindadou H; Kairo KK; Djibo A; Goumbi K; Chanteau S
    Trop Med Int Health; 2005 May; 10(5):435-43. PubMed ID: 15860090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.
    Parent du Châtelet I; Traore Y; Gessner BD; Antignac A; Naccro B; Njanpop-Lafourcade BM; Ouedraogo MS; Tiendrebeogo SR; Varon E; Taha MK
    Clin Infect Dis; 2005 Jan; 40(1):17-25. PubMed ID: 15614687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso.
    Decosas J; Koama JB
    Lancet Infect Dis; 2002 Dec; 2(12):763-5. PubMed ID: 12467693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso.
    Njanpop-Lafourcade BM; Parent du Châtelet I; Sanou O; Alonso JM; Taha MK
    Microbes Infect; 2005 Apr; 7(4):645-9. PubMed ID: 15823512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: main lessons learnt.
    Zombré S; Hacen MM; Ouango G; Sanou S; Adamou Y; Koumaré B; Kondé MK
    Vaccine; 2007 Sep; 25 Suppl 1():A69-71. PubMed ID: 17630052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of W135 meningococcal meningitis in Ghana.
    Forgor AA; Leimkugel J; Hodgson A; Bugri A; Dangy JP; Gagneux S; Smith T; Pluschke G
    Trop Med Int Health; 2005 Dec; 10(12):1229-34. PubMed ID: 16359402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Neisseria meningitidis W135 epidemic in 2012 in Burkina Faso].
    Savadogo M; Kyélem N; Yélbéogo D; Koussoubé D; Tarbagdo F; Ouédraogo A
    Bull Soc Pathol Exot; 2014 Feb; 107(1):15-7. PubMed ID: 24363014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
    Raghunathan PL; Jones JD; Tiendrebéogo SR; Sanou I; Sangaré L; Kouanda S; Dabal M; Lingani C; Elie CM; Johnson S; Ari M; Martinez J; Chatt J; Sidibe K; Schmink S; Mayer LW; Kondé MK; Djingarey MH; Popovic T; Plikaytis BD; Carlone GM; Rosenstein N; Soriano-Gabarró M
    J Infect Dis; 2006 Mar; 193(5):607-16. PubMed ID: 16453255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002.
    Koumaré B; Ouedraogo-Traoré R; Sanou I; Yada AA; Sow I; Lusamba PS; Traoré E; Dabal M; Santamaria M; Hacen MM; Kaboré AB; Caugant DA
    Vaccine; 2007 Sep; 25 Suppl 1():A37-41. PubMed ID: 17521783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135.
    Djibo S; Njanpop Lafourcade BM; Boisier P; Moussa A; Kobo G; Sidikou F; Hien A; Bieboure G; Aguilera JF; Parent du Chatelet I; Gessner BD; Chanteau S
    Trans R Soc Trop Med Hyg; 2006 Jun; 100(6):573-8. PubMed ID: 16406096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study.
    Sié A; Pflüger V; Coulibaly B; Dangy JP; Kapaun A; Junghanss T; Pluschke G; Leimkugel J
    Trop Med Int Health; 2008 Jun; 13(6):861-8. PubMed ID: 18384478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001.
    Ouedraogo-Traore R; Høiby EA; Sanou I; Sangare L; Kyelem N; Ye-Ouattara D; Frøholm LO; Caugant DA
    Scand J Infect Dis; 2002; 34(11):804-7. PubMed ID: 12578146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neisseria meningitidis serogroup W135 meningitis in Senegal from 2000 to 2009].
    Ndour CT; Manga NM; Dia M; Camara B; Cissé F
    Med Mal Infect; 2011 Sep; 41(9):495-7. PubMed ID: 21458934
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa.
    von Gottberg A; du Plessis M; Cohen C; Prentice E; Schrag S; de Gouveia L; Coulson G; de Jong G; Klugman K;
    Clin Infect Dis; 2008 Feb; 46(3):377-86. PubMed ID: 18181736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal carriage and immunity in western Burkina Faso, 2003.
    Yaro S; Traoré Y; Tarnagda Z; Sangaré L; NjanpopLafourcade BM; Drabo A; Findlow H; Borrow R; Nicolas P; Gessner BD; Mueller JE
    Vaccine; 2007 Sep; 25 Suppl 1():A42-6. PubMed ID: 17559988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
    Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
    J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.